Next Article in Journal
Can Nitrogen Excretion of Dairy Cows Be Reduced by Genetic Selection for Low Milk Urea Nitrogen Concentration?
Next Article in Special Issue
Identification of the Potential Role of the Rumen Microbiome in Milk Protein and Fat Synthesis in Dairy Cows Using Metagenomic Sequencing
Previous Article in Journal
Use of Principal Component Analysis to Combine Genetic Merit for Heat Stress and for Fat and Protein Yield in Spanish Autochthonous Dairy Goat Breeds
Previous Article in Special Issue
The Effect of Low-Temperature Crystallization of Fish Oil on the Chemical Composition, Fatty Acid Profile, and Functional Properties of Cow’s Milk
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Production of Bovine Equol-Enriched Milk: A Review

1
Department of Animal Breeding, Animal Nutrition and Biochemistry, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences, 61242 Brno, Czech Republic
2
Department of Biochemistry, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic
*
Author to whom correspondence should be addressed.
Submission received: 30 January 2021 / Revised: 2 March 2021 / Accepted: 4 March 2021 / Published: 8 March 2021
(This article belongs to the Special Issue Raw Milk Quality Can be Improved)

Abstract

:

Simple Summary

Milk and dairy products contain many substances beneficial to human health; moreover, the contents of some of these substances can be enhanced. This is also the case of isoflavones which are compounds of plant origin that can be ingested and metabolized by cattle and, subsequently, secreted into bovine milk. An especially healthful substance called equol is ranked among isoflavone metabolites, commonly produced in the digestive tract of cattle. Equol content in milk can be modified by using feedstuffs with different contents of isoflavones or by milk processing and storage.

Abstract

Milk and dairy products are important sources of nutrients in the human diet because they contain a number of essential substances and other biologically active components. Many of these substances can be modified, and thus offer opportunities to use milk and dairy products as functional food. Isoflavones are particularly important in human nutrition due to their diverse pharmacological and antioxidant properties. The clinical effectiveness of isoflavone-rich products is believed to be dependent on their ability to metabolize daidzein to equol, which may directly exert cancer preventive effects. However, only approximately 30–40% of humans are able to produce equol, while animals, in general, produce equol. Equol is the predominant product of bacterial metabolism of isoflavones and can be found in various amounts in some food of animal origin, especially in milk. Therefore, milk and dairy products can be considered to be sources of equol for humans who are not able to produce this metabolite. When the content of isoflavones in milk is to be modified, two groups of factors should be considered, i.e., dietary factors that include the source of isoflavones and the processing effects on feedstuffs and animal factors that include the intake of isoflavones, ruminal and postruminal changes, and the health and physiological status of animals. The approximate content of isoflavones in milk can be predicted using carry-over rates for different dietary sources or using a formula that describes the relationship between equol concentration in milk and formononetin intake. Processing and storage can affect the content and profile of isoflavones in milk and dairy products.

1. Introduction

Functional food includes natural or processed foods that contain unknown or known biologically active compounds [1]. These compounds have a documented health benefit for treatment or prevention of chronic diseases [2]. Milk and dairy products contain a number of essential substances (vitamins, bioactive peptides, highly absorbable calcium, and probiotic bacteria) and other biologically active components [3]. Furthermore, the composition of numerous of these substances can be modified. These properties, together with their prevalence, offer opportunities to use milk and dairy products as functional foods [4]. Isoflavones, which are studied especially in soya products, are among biologically active substances whose content in milk and dairy products can be increased. Nowadays, studies have focused on modifying cows’ feed to produce dairy products enhanced in isoflavones [5].
For the purpose of this review, a literature search was conducted using Web of Science and Science Direct databases. For the section on “Roles of isoflavones in human health, the Web of Science was searched for articles using combinations of search terms “isoflavones” and “menopause”, “cancer”, “antioxida*”, or “*estrogen*”. For the remaining chapters, the search terms included combinations of terms “isoflavones” and “rumen”, “metabolism”, “milk”, “dairy”, or “feed” and were limited to topic/title/keywords. Titles, abstracts, and finally, full manuscripts were manually reviewed for relevance; only articles published in English in peer-reviewed journals and corresponding to the topic of this review were included. Articles published between 1 January 2010 and 1 September 2020 were preferred. Studies that focused on ruminants other than bovine animals or their milk/dairy products were excluded.

2. Roles of Isoflavones in Human Health

Isoflavones have been associated with diverse beneficial effects on human health; however, they occur in many chemical forms differing in bioavailability and efficacy. Generally, the most effective are isoflavone aglycones and equol, a metabolite of daidzein [6].
The most important property of isoflavones, regarding their role in human health, is their structural similarity to oestrogens (Figure 1). Thanks to this similarity, isoflavones and their metabolites are able to bind to oestrogen receptors and activate them, albeit less effectively than physiological oestrogens [7]. The rank order of isoflavones and their metabolites according to their oestrogenic potency is as follows: equol and genistein > glycitein > daidzein > biochanin A and formononetin. They behave as weak oestrogens, and, on the one hand, in the case of oestrogen deficit, they exert a beneficial effect [8], on the other hand, in high concentrations, they act as oestrogen antagonists, blocking the effects of endogenous oestrogens [9]. Thus, they may be considered to be endocrine disruptors and their effects on a certain part of the population may be negative [10,11]. Predicted maximal plasma concentrations after consumption of soy supplement or an Asian diet are 103 and 10−1 nM for daidzein and equol, respectively, and after consumption of a Western diet, predicted maximal plasma concentrations are 101 and 10−2 nM for daidzein and equol, respectively [12]. The concentrations needed to reach 10% activation of estrogen receptor (ER)-α mediated gene expression as compared with oestradiol activation are approximately 60 and 10 nM for daidzein and equol, respectively [12]. However, while the affinities of oestradiol to the two types of oestrogen receptors, ER-α and ER-β, are approximately equal [13], isoflavones and their metabolites bind to ER-β with greater affinity than to ER-α [14]. Contrary to ER-α binding, binding to ER-β is connected to beneficial antiproliferative activity [15].
Independently from their oestrogen activities, isoflavones also possess antioxidant properties [16]. These effects are due to the hydroxyl groups attached to the aromatic rings. These phenolic groups can be converted to stable radicals during oxidative stress, leading to termination of radical reactions [17]. Human clinical studies that investigated the effects of soy bioactive compounds, including isoflavones, on oxidative stress markers, were recently reviewed by Rizzo [18]. The results were ambiguous. Among eleven studies on isolated isoflavones, ten studies examined the effect of isoflavones on fatty acid oxidative stress; three of the studies found an improvement, one study reported a partial effect, and the other studies did not find any significant effect. Five studies examined the effect of isoflavones on endogenous oxidation markers; three studies found an improvement and two studies did not find any significant effect. In addition, two studies found a reduction of nucleic acid damage.

2.1. Health Effects of Isoflavones and Their Metabolites

Menopausal symptoms are connected to oestrogen deficiency and include vasomotor symptoms (primarily hot flashes), urogenital symptoms, metabolic changes leading to weight gain and higher risk of cardiovascular diseases, and accelerated bone loss leading to osteoporosis [19]. Dietary supplements containing isoflavones can help to reduce the menopausal symptoms (Figure 2) including frequency of hot flashes in menopausal women [20], changes in cholesterol forms [21], and the incidence of subclinical cardiovascular disease [22]. However, at least some of the effects were found only in women who were able to metabolize daidzein into equol [19]. Furthermore, genistein was found to suppress osteoporosis. The mechanism of this beneficial effect probably includes vitamin D receptor [23] and genistein was proven to antagonize the catabolic effect of parathormone in osteoblasts, decrease circulating thyroid hormone levels, increase osteoblastic factors, and decrease osteoclastic factors [24]. Apart from genistein, isoflavone aglycones and equol were shown to have a prophylactic effect against bone mass losses [25]. Thus, the impact of isoflavones on bone health may also be dependent on the ability of women to produce equol [19,26,27,28].
Consumption of soy isoflavones is inversely associated with deaths from cardiovascular diseases [29]. Apart from lowering low density lipoprotein (LDL) cholesterol, isoflavones were suggested to have other beneficial effects on cardiovascular health (Figure 2). Soy isoflavones were shown to lower blood pressure in a hypertensive population [30] and in persons whose serum calcium concentration approached lower or upper physiological limits [31], but not in a population with normal blood pressure [30]. Regarding arterial functions, the results were recently reviewed by Man et al. and, predominantly, isoflavones reduced arterial stiffness [32]. Again, equol was reported to be particularly effective for improving arterial stiffness [33]. Isoflavones are able to induce nitric oxide production, and thus prevent endothelial cell dysfunction [34]. Moreover, in a recent study, biochanin A was reported to have a vasodilatory effect in micromolar concentrations by inhibiting the L-type calcium channels [35].
Isoflavones have been suggested to have anticancer properties (Figure 2), primarily in estrogen-related cancer types, such as uterine, breast, and prostate cancer [36]. The incidence of breast and prostate cancer were found to be lower in Asian countries with a higher daily intake of isoflavones than in Western countries [36]. On the one hand, dietary intake of soy isoflavones (genistein and daidzein) was related to a decreased incidence and mortality of prostate cancer [37]. On the other hand, one study reported that an elevated risk of advanced prostate cancer was associated with the dietary intake of isoflavones [38]. Regarding the molecular mechanisms of anticancer effects, the most studied isoflavone is genistein. Genistein is able to alter apoptosis, the cell cycle and angiogenesis, and to inhibit metastasis [36]. Furthermore, chickpea isoflavones (mainly formononetin and biochanin A), as well as equol, were found to induce apoptosis in breast cancer cells [12,39], although plasma concentrations of equol were not found to correlate with breast cancer risk [40].

2.2. Metabolism of Isoflavones

The main dietary sources of isoflavones in humans are derived from soybean which contains mainly daidzein and genistein [41] (Figure 2). In soybean, isoflavones are almost exclusively conjugated to sugars, and food processing, primarily fermentation, may lead to their partial deglycosylation [42]. After consumption, they are hydrolyzed mainly in the small intestine by bacterial glucosidases [19] (Figure 2). Contrary to glycosides, the released aglycons are bioavailable and can be absorbed across the intestinal epithelium [43]. Part of the isoflavones, however, passes to the large intestine and can be metabolized by intestinal microflora [43]. Genistein is metabolized to dihydrogenistein and further to p-ethyl-phenol and 6-hydroxy-O-desmethylangolensin. Daidzein is converted to dihydrodaidzein and further to S-equol or O-desmethylangolensin (O-DMA) [44]. Equol has a higher oestrogenic potency, higher antioxidant properties, longer half-life, and is absorbed more efficiently across the intestinal wall than daidzein [19,45] and the biological activity of O-DMA is similar or weaker than that of equol [46].
However, equol is produced only in some human individuals [47], depending solely on the intestinal microflora (Figure 2). About 50% of the Asian population and 70–80% of the Western population do not excrete equol, even if they have consumed soybean products or pure isoflavones [19], because, for a reason that is not known yet, they do not harbor equol-producing bacteria [48]. Several bacterial strains that possess the required enzymes (daidzein reductase, dihydrodaidzein reductase, tetrahydrodaidzein reductase, and dihydrodaidzein racemase) and are involved in the metabolism of daidzein to equol have been identified [49,50]. Even though the list of the identified intestinal bacteria involved in the daidzein metabolism may not be exhaustive, the majority seems to be part of the family Coriobacteriaceae [49].
Many studies have proven that, unlike humans, animals commonly produce equol [50]. In ruminants, the metabolites of soybean isoflavones (daidzein, genistein, and glycitein) and red clover isoflavones (formononetin, biochanin A, daidzein, and genistein) include equol, p-ethyl-phenol, and O-DMA [8]. The metabolic conversion of isoflavones takes place mainly in the rumen and the dominant isoflavone found in the digesta of cattle [51] is equol. Relatively large proportions of isoflavones are excreted in milk, and again, the dominant isoflavone is equol [52]. Therefore, milk and dairy products can be considered to be a source of equol for humans not able to produce this metabolite [53,54]. However, for the purposes of functional food production, the feed of dairy cattle, as well as milk processing should be considered, as these parameters substantially influence equol concentrations [53,55,56].

3. Update of Isoflavone Occurrence in Bovine Milk and Dairy Products

According to previous results, the isoflavone concentrations in bovine milk range from non-detectable amounts to units (biochanin A and formononetin), tens (daidzein and glycitein), or hundreds of nanograms per milliliter (genistein) [57,58,59]. The concentration of equol is generally higher, ranging from 4 to 1000 ng/mL in raw milk, whereas the dairy processing may influence the content in both directions [53,54,57]. The content of isoflavones in bovine milk and dairy products is likely the result of direct transfer from the feeds, including leguminous plants, which are naturally rich in isoflavones [60]. The most significant source of isoflavones, concerning dairy cattle feeding, is red clover (Trifolium pratense), a source of biochanin A, genistein, daidzein, and formononetin [5]. Furthermore, soybean (Glycine max) which is a source of daidzein, genistein, and glycitein, is also commonly used as a feed. Even though there are other plants rich in isoflavones, such as kudzu (Pueraria lobate) or licorice (Glycyrrhiza glabra, Glycyrrhiza uralensis), these plants do not significantly alter the volume of isoflavones in bovine milk and in dairy products [5,61].
Several studies have reported that cows grazing a pasture containing red clover [62], fed isoflavone-enriched feed [57], or red clover/grass silages [63] increased the concentration of isoflavones and especially equol in bovine milk as compared with cows grazing on pasture or feed with other botanical compositions [57,62,63]. The addition of soybean increases the isoflavone levels in milk to a lower extent [5] and the isoflavone concentration in such milk is lower as compared with the soy-based food [64]. In any case, milk produced during the indoor feeding periods contains more equol than milk produced during the outdoor feeding period, because pastures contain less red clover than the fields intended for silage production [65]. Accordingly, milk produced during the summer contains less isoflavones than milk produced during the winter [58]. On the one hand, organic retail milk contains, among other phytoestrogens, higher levels of isoflavones than milk originating from conventional or free-range systems. On the other hand, the isoflavone levels do not differ between free-range and conventional milk [58,65]. In conclusion, the isoflavone-enriched feed does not have a positive effect on the milk production [57].

4. Factors Affecting the Content of Isoflavones in Bovine Milk

Factors that should be taken into consideration when the content of isoflavones is to be manipulated are summarized in Figure 3.

4.1. Dietary Factors

4.1.1. Source of Isoflavones

As reviewed recently in [5], red clover-derived or soybean-derived feedstuffs are relevant sources of isoflavones in dairy diets. However, isoflavones also occur in other feedstuffs used for feeding dairy cattle, such as white clover (Trifolium repens) and other clover species [66], lucerne (Medicago sativa) [67] and birdsfoot trefoil (Lotus corniculatus) [68]. However, concentrations of isoflavones in those feedstuffs are considerably lower than in red clover.
In both, red clover and soybean, the content of isoflavones is significantly influenced by variety, planting location, and year or applied fertilization [69,70,71,72].
In red clover, isoflavones are distributed unevenly in aboveground parts and their concentrations depend on the phenological stage, leaf/stem ratio, and the season of the plant [65]. Generally, the highest isoflavone contents were reported in leaves, followed by stems, petioles, and flowers, with formononetin and biochanin A being the predominant isoflavones in all parts [73]. The highest concentrations of formononetin (51%) and biochanin A (40%) were accumulated in leaves during the flowering stage [73]. The concentration ranges of formononetin, biochanin A, daidzein, and genistein at the flowering stage were 2.61–4.40, 1.79–3.32, 0.06–0.14, and 0.36–0.59 mg/g dry matter (DM), respectively. The average total concentration of all four isoflavones at the flowering stage were as follows: 12.29 mg/g DM in leaves, 2.93 mg/g DM in stems, and 1.42 mg/g DM in flowers [73].
In soybeans, the concentration of isoflavones correlated with protein content in seeds [74].

4.1.2. Processing of Feedstuffs

The processing methods applied on isoflavone-rich feedstuffs differ. Generally, forages such as clovers are processed mainly by preserving techniques, either drying (haymaking) or ensiling. For grains such as soybeans, we can use a whole range of mechanical, (hydro) thermal, or chemical treatments. However, the information about the effect of processing on isoflavones content is incomplete because the concentration of isoflavones in final products (e.g., in red clover silage or soybean meal) is usually reported in the literature.
In the case of forages, field-drying of red clover fresh material decreased formononetin and total isoflavones contents by 28 and 22%, respectively, while there was no effect on the concentration of biochanin A was observed [75]. Decreases in formononetin and daidzein contents by about 13 and 7–15%, respectively, were also observed during wilting prior to ensiling [76]. However, Daems et al. [77] found no effect of wilting on isoflavones, except for daidzein that increased twice during the four-day wilting. The effects of ensiling on isoflavones were inconsistent. While Sarelli et al. [76] found about 18% higher concentration of isoflavones in ensiled red clover as compared with wilted or fresh material, Sivesind and Seguin [75] described a decrease in formononetin and total isoflavones content by 20 and 22%, respectively, and no effect of ensiling on biochanin A. A recent study performed in laboratory micro-silos revealed that the isoflavone concentrations drastically decreased within the first two weeks of fermentation, where losses of formononetin and biochanin A were 73% and 66%, respectively, but then the isoflavone concentration was stable for the remaining 5.5 months [77]. However, it should be noted that ensiling is a complex and dynamic process and can be influenced by many factors, among others, by the quality of ensiled forage, pre-ensiling processes, or usage of silage additives [78] and these factors, either individually or in combination, can influence isoflavone concentrations in the preserved material. Further studies are needed to clarify the effect of various ensiling conditions on isoflavones.
In the case of soybean feedstuffs, changes in isoflavones during processing were not systematically studied but some information was applicable from the food industry, although these studies were often focused on interconversion changes between various isoflavones types and alteration in isoflavone profile (e.g., [79]). Solvent-extracted soybean meal is the most common by-product of the oil industry intended for dairy feeding. During the processing, pre-extraction treatments include cracking, dehulling (optional), heating and flaking, and post-extraction treatments include drying, toasting, and grinding. The extraction is done by hexane [80]. Concerning the heat treatment, pasteurization or heating to 140 °C for 20 s had no effect on isoflavones content [81]. Even though hexane extraction does not alter the composition of isoflavones [79], solubility of individual isoflavones in hexane differs, being higher for genistein as compared with daidzein [82].

4.2. Animal Factors

Daily intake of isoflavones depends on the dietary source of isoflavones. As mentioned above, we consider two main isoflavones sources in dairy diets, i.e., red clover and soybean which differ in isoflavone content; the content of isoflavones is higher in red clover than in soybean, i.e., 0.8–11 mg/g and 1.2–4.2 mg/g dry weight, respectively [73,83]. Moreover, red clover is a bulky feed and can represent up to 97% of the dry matter intake. On the other hand, usage of soybean and soybean products in dairy diets is limited because soybeans, as concentrated feedstuffs, are high in protein and also in fat if used in the form of (treated) full-fat products. The maximum inclusion rate reported in the literature was up to 30% of the total diet dry matter [64]. Thus, logically, higher isoflavone intakes are achieved from red clover-based diets (see Table 1). However, we can avoid this limitation by using soybean extracts that can significantly increase the daily isoflavones intake without an imbalance of main nutrients in the diet [57].
Dietary isoflavones are extensively metabolized in the rumen by ruminal microorganisms [51]. Their half-lives in the bovine rumen fluid are 4.3 h for formononetin, 9.3 h for daidzein, 3.9 h for biochanin A, and 5.5 h for genistein [84] and their metabolites occur after 3 h of incubation in the rumen fluid in vitro [55,56]. Concerning the main metabolites, formononetin is demethylated to daidzein, and then further metabolized to equol, a compound with significant estrogenic activity, while biochanin A is demethylated to genistein and further converted to p-ethyl-phenol with no estrogenic activity [5]. The course of metabolism in the rumen can be influenced by the type of diet and by the concentration of isoflavones in the diet [55,56]. Moreover, interaction between isoflavones and rumen bacteria should be also considered, as stimulatory/inhibitory effects of isoflavones on growth of some rumen bacteria were recently reported [85,86,87].
Although the majority of dietary isoflavones is degraded or absorbed in the rumen, small proportions of unmetabolized isoflavones, in concrete 0.4–8% of biochanin A and genistein and 7–15% of formononetin, daidzein, and their metabolite equol were found in omasum [51]. The fate of unmetabolized isoflavones in the intestine of ruminants has not yet been thoroughly described. We suppose that the processes involving metabolism by intestinal bacteria, the conjugation and sulphatation in the gastrointestinal tract, and the re-conjugation in liver are similar as described in human or other animal species, for example, rats [92]. The capacity of epithelial tissue for those reactions in the gastrointestinal tract probably limits the carry-over rate of isoflavones from feed into milk [51].
There are limited studies that have focused on the effect of animal health and physiological status on metabolism of isoflavones. Kowalczyk-Zieba et al. [93] found differences in isoflavone absorption and isoflavone metabolite levels in the blood plasma of cows with experimentally induced mastitis and metritis. These differences were caused by a higher activation of β-glucuronidase during mobilization of the immune system of affected cows. Furthermore, differences in the immunological status of cows connected with the phase of pregnancy can also affect the course of isoflavone metabolism because early pregnant animals had a higher concentration of metabolites in plasma as compared with animals in late pregnancy [94].

5. Prediction of Isoflavones Content in Milk

The quantitative aspect of isoflavone transfer from feed into milk is commonly expressed as the carry-over rate or apparent recovery [88] and can be calculated for individual as well as total isoflavones. Generally, it is calculated as a ratio between isoflavones secreted in milk and isoflavone intake. From the view of human health, the transfer of daidzein (or daidzein + formononentin) and their metabolite equol into milk is the most important, therefore, their carry-over rate is calculated as follows:
c a r r y   o v e r   r a t e   ( μ g / m g ) = d a i d z e i n   ( + f o r m o n o n e t i n ) + e q u o l   s e c r e t e d   i n   m i l k   ( μ g / d ) d a i d z e i n   ( + f o r m o n o n e t i n )   i n t a k e   ( m g / d )
Carry-over rates reported in the literature differ in dependence on the isoflavone source and their daily intake, as documented in the Table 1. However, they can be considered to be a tool for an approximate prediction of isoflavone concentration in milk or for modification of diets for production of desirable amount of isoflavones in milk. Another tool available for prediction purposes is the relationship between equol concentration in milk and formononetin intake, i.e., y = 0.0035x + 0.358, published by Mustonen et al. [95], but the relationship is weak (R2 = 0.20). No relationship is available for soybean-derived isoflavones. Further studies are needed to improve our knowledge of the quantitative aspects of isoflavone transfer from feed into bovine milk.

6. Changes in Isoflavone Contents during Technological Processing of Milk and Dairy Products

Recent data have suggested that the concentration of isoflavones in milk and dairy products can be changed by a number of processes during the course of technological processing (Figure 4) [91].
The most common processes, namely sterilization and pasteurization, do not change the isoflavone level, as thermal stability of isoflavones is up to 120 °C [54,91,96]; similarly, skimming does not seem to alter isoflavone concentration [91]. However, raw milk contains a lower concentration of equol than skimmed milk, which implicates a higher affinity of equol for an aqueous fraction [54]. The processes that are involved in the preparation of yogurts do not affect the quantity of isoflavones [54], although maturation, which is the process that follows the preparation of yogurt, has a minor effect on isoflavone content. The glycitein concentration decreases, whereas the concentrations of daidzein, genistein, and equol remain unaffected [53]. Yogurts obtained from isoflavone-enriched milk contain higher concentrations of daidzein and equol, but the levels of genistein and glycitein remain unchanged [53].
In addition, fermentation causes substantial changes in isoflavone content, primarily in the concentrations of daidzein and glycitein. In contrast to fermentation of soymilk, which leads to increased concentrations of isoflavone aglycones, fermentation and ripening of cows’ milk causes high losses of isoflavones [53,96,97]. Similarly, storage decreases the amounts of isoflavones [96]. A study by Otieno et al. [98] showed a smaller degradation of aglycones than glucosides of isoflavones, but only for soymilk. Accordingly, cheese can contain isoflavones, but the concentrations decrease during the ripening process [96]. Low amounts of isoflavones were found in cream and kefir and, surprisingly, isoflavones were detected in whey [54,91].

7. Conclusions

Isoflavones in human nutrition are particularly important due to their wide range of pharmacological and antioxidant properties. However, the clinical effectiveness of isoflavones depends on the ability to metabolize daidzein to equol, which is true only for approximately 30–40% of humans. Thus, alternative dietary sources of equol in human nutrition are desirable. From the dietary sources, equol-enriched bovine milk seems to be the most suitable product for individuals lacking the ability to produce equol from its dietary precursors. This review showed that for the production of equol-enriched milk, it is important to know the quantitative aspects of isoflavone transfer from feed into milk and to study factors that can influence this transfer. Improved understanding in postruminal metabolic processes is needed as they were identified as factors affecting the carry-over rates; furthermore, not all aspects of rumen metabolism are clear.

Author Contributions

Conceptualization, L.K.; writing—original draft preparation, L.K., V.K. and K.D.; writing—review and editing, L.K., V.K., K.D. and T.K.; supervision, T.K.; project administration, T.K.; funding acquisition, T.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the University of Veterinary and Pharmaceutical Sciences, Internal Grant Agency, grant number 206/2017/FVHE and by the Masaryk University, Grant Agency of Masaryk University, grant number MUNI/A/1604/2020.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Granato, D.; Barba, F.J.; Kovačević, D.B.; Lorenzo, J.M.; Cruz, A.G.; Putnik, P. Functional Foods: Product Development, Technological Trends, Efficacy Testing, and Safety. Annu. Rev. Food Sci. Technol. 2020, 11, 93–118. [Google Scholar] [CrossRef] [Green Version]
  2. Martirosyan, D.M.; Singh, J. A New Definition of Functional Food by FFC: What Makes a New Definition Unique? Funct. Foods Health Dis. 2015, 5, 209–223. [Google Scholar] [CrossRef]
  3. Tunick, M.H.; Van Hekken, D.L. Dairy Products and Health: Recent Insights. J. Agric. Food Chem. 2015, 63, 9381–9388. [Google Scholar] [CrossRef] [PubMed]
  4. Bhat, Z.F.; Bhat, H. Milk and Dairy Products as Functional Foods: A Review. Int. J. Dairy Sci. 2011, 6, 1–12. [Google Scholar] [CrossRef] [Green Version]
  5. Křížová, L.; Dadáková, K.; Kašparovská, J.; Kašparovský, T. Isoflavones. Molecules 2019, 24, 1076. [Google Scholar] [CrossRef] [Green Version]
  6. de Ávila, A.R.A.; de Queirós, L.D.; Ueta, T.M.; Macedo, G.A.; Macedo, J.A. Exploring in Vitro Effects of Biotransformed Isoflavones Extracts: Antioxidant, Antiinflammatory, and Antilipogenic. J. Food Biochem. 2019, 43, e12850. [Google Scholar] [CrossRef]
  7. Gray, S.L.; Lackey, B.R. Optimizing a Recombinant Estrogen Receptor Binding Assay for Analysis of Herbal Extracts. J. Herb. Med. 2019, 15, 100252. [Google Scholar] [CrossRef]
  8. Wójciak–Kosior, M.; Dresler, S.; Sowa, I.; Łuć, K.; Staniak, M.; Latalski, M.; Zapała-Kiełbowicz, K.; Kocjan, R. Effect of various strontium concentrations on its uptake and the content of isoflavones in soybean sprouts. Acta Biol. Crac. Bot. 2019, 61, 7–12. [Google Scholar] [CrossRef]
  9. Liu, Y.; Hassan, S.; Kidd, B.N.; Garg, G.; Mathesius, U.; Singh, K.B.; Anderson, J.P. Ethylene Signaling Is Important for Isoflavonoid-Mediated Resistance to Rhizoctonia solani in Roots of Medicago Truncatula. Mol. Plant-Microbe Interact. 2017, 30, 691–700. [Google Scholar] [CrossRef] [Green Version]
  10. Wocławek-Potocka, I.; Mannelli, C.; Boruszewska, D.; Kowalczyk-Zieba, I.; Waśniewski, T.; Skarżyński, D.J. Diverse Effects of Phytoestrogens on the Reproductive Performance: Cow as a Model. Int. J. Endocrinol. 2013, 650984. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Franke, A.A.; Lai, J.F.; Halm, B.M. Absorption, Distribution, Metabolism, and Excretion of Isoflavonoids after Soy Intake. Arch. Biochem. Biophys. 2014, 559, 24–28. [Google Scholar] [CrossRef] [Green Version]
  12. Wang, J.; Yu, H.; Yili, A.; Gao, Y.; Hao, L.; Aisa, H.A.; Liu, S. Identification of Hub Genes and Potential Molecular Mechanisms of Chickpea Isoflavones on MCF-7 Breast Cancer Cells by Integrated Bioinformatics Analysis. Ann. Transl. Med. 2020, 8, 86. [Google Scholar] [CrossRef]
  13. Cheverasan, A.; Mioc, M.; Simu, S.; Soica, C.; Dehelean, C.; Szasz, F.; Navolan, D.; Poenaru, M. Binding Affinity of 17-b-Ethinylestradiol to Normal and Mutant Types of Estrogen Receptors an in Silico Evaluation. Rev. Chim. 2018, 69, 2067–2070. [Google Scholar] [CrossRef]
  14. Vitale, D.C.; Piazza, C.; Melilli, B.; Drago, F.; Salomone, S. Isoflavones: Estrogenic Activity, Biological Effect and Bioavailability. Eur. J. Drug Metab. Pharmacokinet. 2013, 38, 15–25. [Google Scholar] [CrossRef]
  15. Cipolletti, M.; Solar Fernandez, V.; Montalesi, E.; Marino, M.; Fiocchetti, M. Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: The Modulation of Estrogen Receptors (ERs) Signaling. Int. J. Mol. Sci. 2018, 19, 2624. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Abo-elsoud, M.A.; Hashem, N.M.; Nour El-Din, A.N.M.; Kamel, K.I.; Hassan, G.A. Soybean Isoflavone Affects in Rabbits: Effects on Metabolism, Antioxidant Capacity, Hormonal Balance and Reproductive Performance. Anim. Reprod. Sci. 2019, 203, 52–60. [Google Scholar] [CrossRef] [PubMed]
  17. Peres, J.A.; Domínguez, J.R.; Beltran-Heredia, J. Reaction of Phenolic Acids with Fenton-Generated Hydroxyl Radicals: Hammett Correlation. Desalination 2010, 252, 167–171. [Google Scholar] [CrossRef]
  18. Rizzo, G. The Antioxidant Role of Soy and Soy Foods in Human Health. Antioxidants 2020, 9, 635. [Google Scholar] [CrossRef]
  19. Monteiro, N.E.S.; Queirós, L.D.; Lopes, D.B.; Pedro, A.O.; Macedo, G.A. Impact of Microbiota on the Use and Effects of Isoflavones in the Relief of Climacteric Symptoms in Menopausal Women—A Review. J. Funct. Foods 2018, 41, 100–111. [Google Scholar] [CrossRef]
  20. Chen, L.-R.; Ko, N.-Y.; Chen, K.-H. Isoflavone Supplements for Menopausal Women: A Systematic Review. Nutrients 2019, 11, 2649. [Google Scholar] [CrossRef] [Green Version]
  21. Carmignani, L.O.; Pedro, A.O.; da Costa-Paiva, L.H.S.; Pinto-Neto, A.M. The Effect of Soy Dietary Supplement and Low Dose of Hormone Therapy on Main Cardiovascular Health Biomarkers: A Randomized Controlled Trial. Rev. Bras. Ginecol. Obs. 2014, 36, 251–258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Ferreira, L.L.; Silva, T.R.; Maturana, M.A.; Spritzer, P.M. Dietary Intake of Isoflavones Is Associated with a Lower Prevalence of Subclinical Cardiovascular Disease in Postmenopausal Women: Cross-Sectional Study. J. Hum. Nutr. Diet. 2019, 32, 810–818. [Google Scholar] [CrossRef] [PubMed]
  23. Ye, C.F.; Pan, Y.M.; Zhou, H. Regulation of Vitamin D Receptor and Genistein on Bone Metabolism in Mouse Osteoblasts and the Molecular Mechanism of Osteoporosis. J. Biol. Regul. Homeost. Agents 2018, 32, 497–505. [Google Scholar] [PubMed]
  24. Filipović, B.; Šošić-Jurjević, B.; Ajdžanović, V.; Živanović, J.; Manojlović-Stojanoski, M.; Nestorović, N.; Ristić, N.; Trifunović, S.; Milošević, V. The Phytoestrogen Genistein Prevents Trabecular Bone Loss and Affects Thyroid Follicular Cells in a Male Rat Model of Osteoporosis. J. Anat. 2018, 233, 204–212. [Google Scholar] [CrossRef]
  25. Tousen, Y.; Ezaki, J.; Fujii, Y.; Ueno, T.; Nishimuta, M.; Ishimi, Y. Natural S-Equol Decreases Bone Resorption in Postmenopausal, Non-Equol-Producing Japanese Women: A Pilot Randomized, Placebo-Controlled Trial. Menopause 2011, 18, 563–574. [Google Scholar] [CrossRef] [PubMed]
  26. Ishimi, Y. Dietary Equol and Bone Metabolism in Postmenopausal Japanese Women and Osteoporotic Mice. J. Nutr. 2010, 140, 1373S–1376S. [Google Scholar] [CrossRef] [Green Version]
  27. Taku, K.; Melby, M.K.; Nishi, N.; Omori, T.; Kurzer, M.S. Soy Isoflavones for Osteoporosis: An Evidence-Based Approach. Maturitas 2011, 70, 333–338. [Google Scholar] [CrossRef]
  28. Pawlowski, J.W.; Martin, B.R.; McCabe, G.P.; McCabe, L.; Jackson, G.S.; Peacock, M.; Barnes, S.; Weaver, C.M. Impact of Equol-Producing Capacity and Soy-Isoflavone Profiles of Supplements on Bone Calcium Retention in Postmenopausal Women: A Randomized Crossover Trial. Am. J. Clin. Nutr. 2015, 102, 695–703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Nachvak, S.M.; Moradi, S.; Anjom-shoae, J.; Rahmani, J.; Nasiri, M.; Maleki, V.; Sadeghi, O. Soy, Soy Isoflavones, and Protein Intake in Relation to Mortality from All Causes, Cancers, and Cardiovascular Diseases: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. J. Acad. Nutr. Diet. 2019, 119, 1483–1500. [Google Scholar] [CrossRef]
  30. Liu, X.X.; Li, S.H.; Chen, J.Z.; Sun, K.; Wang, X.J.; Wang, X.G.; Hui, R.T. Effect of Soy Isoflavones on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 463–470. [Google Scholar] [CrossRef]
  31. Lu, L.-J.W.; Chen, N.-W.; Nayeem, F.; Nagamani, M.; Anderson, K.E. Soy Isoflavones Interact with Calcium and Contribute to Blood Pressure Homeostasis in Women: A Randomized, Double-Blind, Placebo Controlled Trial. Eur. J. Nutr. 2020, 59, 2369–2381. [Google Scholar] [CrossRef]
  32. Man, B.; Cui, C.; Zhang, X.; Sugiyama, D.; Barinas-Mitchell, E.; Sekikawa, A. The Effect of Soy Isoflavones on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Eur. J. Nutr. 2021, 60, 603–614. [Google Scholar] [CrossRef]
  33. Sekikawa, A.; Ihara, M.; Lopez, O.; Kakuta, C.; Lopresti, B.; Higashiyama, A.; Aizenstein, H.; Chang, Y.-F.; Mathis, C.; Miyamoto, Y.; et al. Effect of S-Equol and Soy Isoflavones on Heart and Brain. Curr. Cardiol. Rev. 2019, 15, 114–135. [Google Scholar] [CrossRef] [PubMed]
  34. Yamagata, K. Soy Isoflavones Inhibit Endothelial Cell Dysfunction and Prevent Cardiovascular Disease. J. Cardiovasc. Pharmacol. 2019, 74, 201–209. [Google Scholar] [CrossRef] [PubMed]
  35. Migkos, T.; Pourova, J.; Voprsalova, M.; Auger, C.; Schini-Kerth, V.; Mladenka, P. Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation of the Coronary Artery Through the Calcium Channel and CGMP-Dependent Pathway. Planta Med. 2020, 86, 708–716. [Google Scholar] [CrossRef] [PubMed]
  36. Sahin, I.; Bilir, B.; Ali, S.; Sahin, K.; Kucuk, O. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy. Integr. Cancer Ther. 2019, 18, 153473541983531. [Google Scholar] [CrossRef] [Green Version]
  37. Pabich, M.; Materska, M. Biological Effect of Soy Isoflavones in the Prevention of Civilization Diseases. Nutrients 2019, 11, 1660. [Google Scholar] [CrossRef] [Green Version]
  38. Reger, M.K.; Zollinger, T.W.; Liu, Z.; Jones, J.F.; Zhang, J. Dietary Intake of Isoflavones and Coumestrol and the Risk of Prostate Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Dietary Phytoestrogens and Prostate Cancer. Int. J. Cancer 2018, 142, 719–728. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Zhang, J.; Ren, L.; Yu, M.; Liu, X.; Ma, W.; Huang, L.; Li, X.; Ye, X. S-Equol Inhibits Proliferation and Promotes Apoptosis of Human Breast Cancer MCF-7 Cells via Regulating MiR-10a-5p and PI3K/AKT Pathway. Arch. Biochem. Biophys. 2019, 672, 108064. [Google Scholar] [CrossRef] [PubMed]
  40. Atkinson, C.; Ray, R.M.; Li, W.; Lin, M.-G.; Gao, D.L.; Shannon, J.; Stalsberg, H.; Porter, P.L.; Frankenfeld, C.L.; Wähälä, K.; et al. Plasma Equol Concentration Is Not Associated with Breast Cancer and Fibrocystic Breast Conditions among Women in Shanghai, China. Nutr. Res. 2016, 36, 863–871. [Google Scholar] [CrossRef] [Green Version]
  41. Delgado, L.; Heckmann, C.M.; Di Pisa, F.; Gourlay, L.; Paradisi, F. Release of Soybean Isoflavones by Using a Β-Glucosidase from Alicyclobacillus herb. ChemBioChem 2020. [Google Scholar] [CrossRef]
  42. Silva, F.; Lemos, T.C.; Sandôra, D.; Monteiro, M.; Perrone, D. Fermentation of Soybean Meal Improves Isoflavone Metabolism after Soy Biscuit Consumption by Adults. J. Sci. Food Agric. 2020, 100, 2991–2998. [Google Scholar] [CrossRef]
  43. Marín, L.; Miguélez, E.M.; Villar, C.J.; Lombó, F. Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties. BioMed Res. Int. 2015, 905215. [Google Scholar] [CrossRef] [Green Version]
  44. Gaya, P.; Medina, M.; Sánchez-Jiménez, A.; Landete, J. Phytoestrogen Metabolism by Adult Human Gut Microbiota. Molecules 2016, 21, 1034. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Decroos, K.; Vanhemmens, S.; Cattoir, S.; Boon, N.; Verstraete, W. Isolation and Characterisation of an Equol-Producing Mixed Microbial Culture from a Human Faecal Sample and Its Activity under Gastrointestinal Conditions. Arch. Microbiol. 2005, 183, 45–55. [Google Scholar] [CrossRef] [PubMed]
  46. Choi, E.J.; Kim, G.-H. The Antioxidant Activity of Daidzein Metabolites, O-Desmethylangolensin and Equol, in HepG2 Cells. Mol. Med. Rep. 2014, 9, 328–332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Sánchez-Calvo, J.M.; Rodríguez-Iglesias, M.A.; Molinillo, J.M.G.; Macías, F.A. Soy Isoflavones and Their Relationship with Microflora: Beneficial Effects on Human Health in Equol Producers. Phytochem Rev. 2013, 12, 979–1000. [Google Scholar] [CrossRef]
  48. Braune, A.; Blaut, M. Evaluation of Inter-Individual Differences in Gut Bacterial Isoflavone Bioactivation in Humans by PCR-Based Targeting of Genes Involved in Equol Formation. J. Appl. Microbiol. 2018, 124, 220–231. [Google Scholar] [CrossRef]
  49. Liang, W.; Zhao, L.; Zhang, J.; Fang, X.; Zhong, Q.; Liao, Z.; Wang, J.; Guo, Y.; Liang, H.; Wang, L. Colonization Potential to Reconstitute a Microbe Community in Pseudo Germ-Free Mice After Fecal Microbe Transplant From Equol Producer. Front. Microbiol. 2020, 11, 1221. [Google Scholar] [CrossRef] [PubMed]
  50. Mayo, B.; Vázquez, L.; Flórez, A.B. Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects. Nutrients 2019, 11, 2231. [Google Scholar] [CrossRef] [Green Version]
  51. Njåstad, K.M.; Adler, S.A.; Hansen-Møller, J.; Thuen, E.; Gustavsson, A.-M.; Steinshamn, H. Gastrointestinal Metabolism of Phytoestrogens in Lactating Dairy Cows Fed Silages with Different Botanical Composition. J. Dairy Sci. 2014, 97, 7735–7750. [Google Scholar] [CrossRef] [PubMed]
  52. Mustonen, E.; Taponen, S.; Andersson, M.; Sukura, A.; Katila, T.; Taponen, J. Fertility and Growth of Nulliparous Ewes after Feeding Red Clover Silage with High Phyto-Oestrogen Concentrations. Animal 2014, 8, 1699–1705. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Kašparovská, J.; Dadáková, K.; Lochman, J.; Hadrová, S.; Křížová, L.; Kašparovský, T. Changes in Equol and Major Soybean Isoflavone Contents during Processing and Storage of Yogurts Made from Control or Isoflavone-Enriched Bovine Milk Determined Using LC-MS (TOF) Analysis. Food Chem. 2017, 222, 67–73. [Google Scholar] [CrossRef] [PubMed]
  54. Lefevre, A.; Daems, F.; Focant, M.; Peeters, J.; Ninane, V.; Larondelle, Y.; Froidmont, E. The Effect of Commonly Used Dairy Processing Techniques and Unit Operations on the Equol Content of Dairy Products. Int. Dairy J. 2019, 93, 30–34. [Google Scholar] [CrossRef]
  55. Trnková, A.; Šancová, K.; Zapletalová, M.; Kašparovská, J.; Dadáková, K.; Křížová, L.; Lochman, J.; Hadrová, S.; Ihnatová, I.; Kašparovský, T. Determination of in Vitro Isoflavone Degradation in Rumen Fluid. J. Dairy Sci. 2018, 101, 5134–5144. [Google Scholar] [CrossRef]
  56. Dadáková, K.; Trnková, A.; Kašparovská, J.; Křížová, L.; Lochman, J.; Kašparovský, T. In Vitro Metabolism of Red Clover Isoflavones in Rumen Fluid. J. Anim. Physiol. Anim. Nutr. 2020, 104, 1647–1654. [Google Scholar] [CrossRef]
  57. Kasparovska, J.; Krizova, L.; Lochman, J.; Dadakova, K.; Kasparovsky, T. Soybean-Derived Isoflavone Determination in Rumen Fluid and Milk by LC–MS-(TOF). J. Chromatogr. Sci. 2016, 54, 997–1003. [Google Scholar] [CrossRef] [Green Version]
  58. Nørskov, N.P.; Givens, I.; Purup, S.; Stergiadis, S. Concentrations of Phytoestrogens in Conventional, Organic and Free-Range Retail Milk in England. Food Chem. 2019, 295, 1–9. [Google Scholar] [CrossRef]
  59. Bláhová, L.; Kohoutek, J.; Procházková, T.; Prudíková, M.; Bláha, L. Phytoestrogens in Milk: Overestimations Caused by Contamination of the Hydrolytic Enzyme Used during Sample Extraction. J. Dairy Sci. 2016, 99, 6973–6982. [Google Scholar] [CrossRef]
  60. Clarke, H.J.; Griffin, C.; Rai, D.K.; O’Callaghan, T.F.; O’Sullivan, M.G.; Kerry, J.P.; Kilcawley, K.N. Dietary Compounds Influencing the Sensorial, Volatile and Phytochemical Properties of Bovine Milk. Molecules 2020, 25, 26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Jungbauer, A.; Medjakovic, S. Phytoestrogens and the Metabolic Syndrome. J. Steroid Biochem. Mol. Biol. 2014, 139, 277–289. [Google Scholar] [CrossRef] [PubMed]
  62. Adler, S.A.; Purup, S.; Hansen-Møller, J.; Thuen, E.; Gustavsson, A.-M.; Steinshamn, H. Phyto-Oestrogens and Their Metabolites in Milk Produced on Two Pastures with Different Botanical Compositions. Livest. Sci. 2014, 163, 62–68. [Google Scholar] [CrossRef]
  63. Höjer, A.; Adler, S.; Purup, S.; Hansen-Møller, J.; Martinsson, K.; Steinshamn, H.; Gustavsson, A.-M. Effects of Feeding Dairy Cows Different Legume-Grass Silages on Milk Phytoestrogen Concentration. J. Dairy Sci. 2012, 95, 4526–4540. [Google Scholar] [CrossRef] [PubMed]
  64. Flachowsky, G.; Hünerberg, M.; Meyer, U.; Kammerer, D.R.; Carle, R.; Goerke, M.; Eklund, M. Isoflavone Concentration of Soybean Meal from Various Origins and Transfer of Isoflavones into Milk of Dairy Cows. J. Verbrauch. Lebensm. 2011, 6, 449–456. [Google Scholar] [CrossRef]
  65. Adler, S.A.; Purup, S.; Hansen-Møller, J.; Thuen, E.; Steinshamn, H. Phytoestrogens and Their Metabolites in Bulk-Tank Milk: Effects of Farm Management and Season. PLoS ONE 2015, 10, e0127187. [Google Scholar] [CrossRef] [Green Version]
  66. Duan, T.; Ma, H.; Dong, Y.; Yang, F.; Liu, X. Microemulsion Liquid Chromatographic Method for Simultaneous Separation and Determination of Five Isoflavones in Red Clover. J. Liq. Chromatogr. Relat. Technol. 2021, 1–8. [Google Scholar] [CrossRef]
  67. Silva, L.R.; Pereira, M.J.; Azevedo, J.; Gonçalves, R.F.; Valentão, P.; de Pinho, P.G.; Andrade, P.B. Glycine max (L.) Merr., Vigna radiata, L. and Medicago sativa, L. Sprouts: A Natural Source of Bioactive Compounds. Food Res. Int. 2013, 50, 167–175. [Google Scholar] [CrossRef]
  68. Cornara, L.; Xiao, J.; Burlando, B. Therapeutic Potential of Temperate Forage Legumes: A Review. Crit. Rev. Food Sci. Nutr. 2016, 56, S149–S161. [Google Scholar] [CrossRef]
  69. Król-Grzymała, A.; Amarowicz, R. Phenolic Compounds of Soybean Seeds from Two European Countries and Their Antioxidant Properties. Molecules 2020, 25, 2075. [Google Scholar] [CrossRef]
  70. Berhow, M.A.; Singh, M.; Bowman, M.J.; Price, N.P.J.; Vaughn, S.F.; Liu, S.X. Quantitative NIR Determination of Isoflavone and Saponin Content of Ground Soybeans. Food Chem. 2020, 317, 126373. [Google Scholar] [CrossRef]
  71. Kim, E.-H.; Lee, O.-K.; Kim, J.K.; Kim, S.-L.; Lee, J.; Kim, S.-H.; Chung, I.-M. Isoflavones and Anthocyanins Analysis in Soybean (Glycine max (L.) Merill) from Three Different Planting Locations in Korea. Field Crop. Res. 2014, 156, 76–83. [Google Scholar] [CrossRef]
  72. Du, W.; Yue, Y.; Tian, X. Variation of Isoflavones Production in Red Clover as Related to Environment, Growth Stage and Year. Acta Aliment. 2012, 41, 211–220. [Google Scholar] [CrossRef]
  73. Lemežienė, N.; Padarauskas, A.; Butkutė, B.; Cesevičienė, J.; Taujenis, L.; Norkevičienė, E.; Norkevičienė, E. The Concentration of Isoflavones in Red Clover (Trifolium pratense, L.) at Flowering Stage. Zemdirb. Agric. 2015, 102, 443–448. [Google Scholar] [CrossRef] [Green Version]
  74. Wang, X.; Liu, S.; Yin, X.; Bellaloui, N.; McClure, M.A.; Mengistu, A. Soybean Seed Isoflavones Respond Differentially to Phosphorus Applications in Low and High Phosphorus Soils. Nutr. Cycl. Agroecosyst. 2019, 113, 217–230. [Google Scholar] [CrossRef]
  75. Sivesind, E.; Seguin, P. Effects of the Environment, Cultivar, Maturity, and Preservation Method on Red Clover Isoflavone Concentration. J. Agric. Food Chem. 2005, 53, 6397–6402. [Google Scholar] [CrossRef]
  76. Sarelli, L.; Tuori, M.; Saastamoinen, I.; Syrjälä-qvist, L.; Saloniemi, H. Phytoestrogen Content of Birdsfoot Trefoil and Red Clover: Effects of Growth Stage and Ensiling Method. Acta Agric. Scand. Sect. A Anim. Sci. 2003, 53, 58–63. [Google Scholar] [CrossRef]
  77. Daems, F.; Decruyenaere, V.; Agneessens, R.; Lognay, G.; Romnee, J.M.; Froidmont, É. Changes in the Isoflavone Concentration in Red Clover (Trifolium pratense, L.) during Ensiling and Storage in Laboratory-Scale Silos. Anim. Feed Sci. Technol. 2016, 217, 36–44. [Google Scholar] [CrossRef]
  78. Charmley, E. Towards Improved Silage Quality—A Review. Can. J. Anim. Sci. 2001, 81, 157–168. [Google Scholar] [CrossRef]
  79. Barnes, S. The Biochemistry, Chemistry and Physiology of the Isoflavones in Soybeans and Their Food Products. Lymphat. Res. Biol. 2010, 8, 89–98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  80. Dunford, N.T. Advancements in Oil and Oilseed Processing. In Food and Industrial Bioproducts and Bioprocessing; Dunford, N.T., Ed.; Wiley-Blackwell: Oxford, UK, 2012; pp. 115–143. ISBN 978-1-119-94608-3. [Google Scholar]
  81. Ferreira, C.D.; Ziegler, V.; Schwanz Goebel, J.T.; Hoffmann, J.F.; Carvalho, I.R.; Chaves, F.C.; de Oliveira, M. Changes in Phenolic Acid and Isoflavone Contents during Soybean Drying and Storage. J. Agric. Food Chem. 2019, 67, 1146–1155. [Google Scholar] [CrossRef]
  82. Nan, G.; Shi, J.; Huang, Y.; Sun, J.; Lv, J.; Yang, G.; Li, Y. Dissociation Constants and Solubilities of Daidzein and Genistein in Different Solvents. J. Chem. Eng. Data 2014, 59, 1304–1311. [Google Scholar] [CrossRef]
  83. Zhang, J.; Ge, Y.; Han, F.; Li, B.; Yan, S.; Sun, J.; Wang, L. Isoflavone Content of Soybean Cultivars from Maturity Group 0 to VI Grown in Northern and Southern China. J. Am. Oil Chem. Soc. 2014, 91, 1019–1028. [Google Scholar] [CrossRef] [Green Version]
  84. Dickinson, J.M.; Smith, G.R.; Randel, R.D.; Pemberton, I.J. In Vitro Metabolism of Formononetin and Biochanin A in Bovine Rumen Fluid. J. Anim. Sci. 1988, 66, 1969–1973. [Google Scholar] [CrossRef]
  85. Harlow, B.E.; Flythe, M.D.; Aiken, G.E. Effect of Biochanin A on Corn Grain (Zea mays) Fermentation by Bovine Rumen Amylolytic Bacteria. J. Appl. Microbiol. 2017, 122, 870–880. [Google Scholar] [CrossRef] [PubMed]
  86. Harlow, B.E.; Flythe, M.D.; Aiken, G.E. Biochanin A Improves Fibre Fermentation by Cellulolytic Bacteria. J. Appl. Microbiol. 2018, 124, 58–66. [Google Scholar] [CrossRef] [PubMed]
  87. Melchior, E.A.; Smith, J.K.; Schneider, L.G.; Mulliniks, J.T.; Bates, G.E.; Flythe, M.D.; Klotz, J.L.; Ji, H.; Goodman, J.P.; Lee, A.R.; et al. Effects of Endophyte-Infected Tall Fescue Seed and Red Clover Isoflavones on Rumen Microbial Populations and Physiological Parameters of Beef Cattle. Transl. Anim. Sci. 2018, 3, 315–328. [Google Scholar] [CrossRef]
  88. Steinshamn, H.; Purup, S.; Thuen, E.; Hansen-Møller, J. Effects of Clover-Grass Silages and Concentrate Supplementation on the Content of Phytoestrogens in Dairy Cow Milk. J. Dairy Sci. 2008, 91, 2715–2725. [Google Scholar] [CrossRef]
  89. Andersen, C.; Nielsen, T.S.; Purup, S.; Kristensen, T.; Eriksen, J.; Søegaard, K.; Sørensen, J.; Fretté, X.C. Phyto-Oestrogens in Herbage and Milk from Cows Grazing White Clover, Red Clover, Lucerne or Chicory-Rich Pastures. Animal 2009, 3, 1189–1195. [Google Scholar] [CrossRef] [Green Version]
  90. Třináctý, J.; Křížová, L.; Schulzová, V.; Hajšlová, J.; Hanuš, O. The Effect of Feeding Soybean-Derived Phytoestogens on Their Concentration in Plasma and Milk of Lactating Dairy Cows. Arch. Anim. Nutr. 2009, 63, 219–229. [Google Scholar] [CrossRef]
  91. Křížová, L.; Třináctý, J.; Hajšlová, J.; Havlíková, Š. The Effect of Technological Processing on the Content of Isoflavones in Bovine Milk and Dairy Products. In Soybean-Applications and Technology; Ng, T.-B., Ed.; InTech: Rijeka, Croatia, 2011; ISBN 978-953-307-207-4. [Google Scholar]
  92. Piskula, M.K.; Yamakoshi, J.; Iwai, Y. Daidzein and Genistein but Not Their Glucosides Are Absorbed from the Rat Stomach. FEBS Lett. 1999, 447, 287–291. [Google Scholar] [CrossRef] [Green Version]
  93. Kowalczyk-Zieba, I.; Woclawek-Potocka, I.; Piskula, M.K.; Piotrowska-Tomala, K.K.; Boruszewska, D.; Bah, M.M.; Siemieniuch, M.J.; Skarzynski, D.J. Experimentally Induced Mastitis and Metritis Modulate Soy Bean Derived Isoflavone Biotransformation in Diary Cows. Theriogenology 2011, 76, 1744–1755. [Google Scholar] [CrossRef] [PubMed]
  94. Woclawek-Potocka, I.; Piskula, M.K.; Bah, M.; Siemieniuch, M.J.; Korzekwa, A.; Brzezicka, E.; Skarzynski, D.J. Concentrations of Isoflavones and Their Metabolites in the Blood of Pregnant and Non-Pregnant Heifers Fed Soy Bean. J. Reprod. Dev. 2008, 54, 358–363. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Mustonen, E.A.; Tuori, M.; Saastamoinen, I.; Taponen, J.; Wähälä, K.; Saloniemi, H.; Vanhatalo, A. Equol in Milk of Dairy Cows Is Derived from Forage Legumes Such as Red Clover. Br. J. Nutr. 2009, 102, 1552–1556. [Google Scholar] [CrossRef] [Green Version]
  96. Křížová, L.; Veselý, A.; Třináctý, J.; Schulzová, V.; Hurajová, A.; Hajšlová, J.; Kvasničková, E.; Havlíková, Š. Changes in Isoflavones Concentrations in Cheese during Processing and Ripening. Acta Univ. Agric. Silvic. Mendel. Brun. 2011, 59, 153–162. [Google Scholar] [CrossRef] [Green Version]
  97. Marazza, J.A.; Nazareno, M.A.; de Giori, G.S.; Garro, M.S. Enhancement of the Antioxidant Capacity of Soymilk by Fermentation with Lactobacillus Rhamnosus. J. Funct. Foods 2012, 4, 594–601. [Google Scholar] [CrossRef]
  98. Otieno, D.O.; Ashton, J.F.; Shah, N.P. Stability of Isoflavone Phytoestrogens in Fermented Soymilk with Bifidobacterium Animalis Bb12 during Storage at Different Temperatures. Int. J. Food Sci. Technol. 2006, 41, 1182–1191. [Google Scholar] [CrossRef]
Figure 1. Comparison of estradiol and equol chemical structures.
Figure 1. Comparison of estradiol and equol chemical structures.
Animals 11 00735 g001
Figure 2. Factors affecting isoflavone bioavailability and isoflavone health effects. Created with BioRender.com.
Figure 2. Factors affecting isoflavone bioavailability and isoflavone health effects. Created with BioRender.com.
Animals 11 00735 g002
Figure 3. Factors affecting the concentration of isoflavones in milk.
Figure 3. Factors affecting the concentration of isoflavones in milk.
Animals 11 00735 g003
Figure 4. Technological processing affecting concentration of isoflavones in milk.
Figure 4. Technological processing affecting concentration of isoflavones in milk.
Animals 11 00735 g004
Table 1. The carry-over rates of daidzein (+formononetin) from feed into bovine milk from selected dietary sources in relation with the isoflavones intake.
Table 1. The carry-over rates of daidzein (+formononetin) from feed into bovine milk from selected dietary sources in relation with the isoflavones intake.
Source of IsoflavonesIntake of Daidzein
(+Formononetin)
(mg/d)
Carry-Over Rate 1
(μg/mg)
Source
Red clover/grass silage48,4100.21[88]
Red clover/grass silage + concentrate 38,7000.24[88]
Red clover grass silage, 2nd cut40,3501.07[63]
Red clover grass silage, 3rd cut39,9500.96[63]
White clover/grass silage22491.20[88]
White clover/grass silage + concentrate21060.92[88]
Birdsfoot Trefoil grass silage 25201.83[63]
Grass/clover silagenot given1.23[89]
Lucerne silagenot given0.77[89]
40% Soybean isoflavone extract10,6180.50[57]
Extruded full-fat soybean13191.3[90]
Extruded full-fat soybean4392.5[91]
Soybean mealnot given2.0–4.4 2[64]
1, calculated as (sum of equol, formononetin, and daidzein secreted in milk)/(sum of formononetin and daidzein intake). 2, The mean total carry-over rate of isoflavones declined with increasing isoflavones intake according to the formula y = −0.0001x + 0.0006 (R2 = 0.69).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Křížová, L.; Křešťáková, V.; Dadáková, K.; Kašparovský, T. Production of Bovine Equol-Enriched Milk: A Review. Animals 2021, 11, 735. https://0-doi-org.brum.beds.ac.uk/10.3390/ani11030735

AMA Style

Křížová L, Křešťáková V, Dadáková K, Kašparovský T. Production of Bovine Equol-Enriched Milk: A Review. Animals. 2021; 11(3):735. https://0-doi-org.brum.beds.ac.uk/10.3390/ani11030735

Chicago/Turabian Style

Křížová, Ludmila, Veronika Křešťáková, Kateřina Dadáková, and Tomáš Kašparovský. 2021. "Production of Bovine Equol-Enriched Milk: A Review" Animals 11, no. 3: 735. https://0-doi-org.brum.beds.ac.uk/10.3390/ani11030735

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop